Prohibition of Insider Trading

DR. LAL PATHLABS LIMITED

General information about company

Scrip Code		539524
NSE Symbol		LALPATHLAB
MSEI Symbol		NOTLISTED
Name of the Signatory		VINAY GUJRAL
Designation of Signatory		Company Secretary and Compliance Officer
Place		GURUGRAM
Date of Filing		05-08-2026
ISIN Code		INE600L01024
Disclosure under Regulation		Regulation 7 (2)
Revised Filing		No

PIT Disclosure

Sr. No.	Type of instrument	Description of type of instrument (applicable in case of other is selected)	Category of person	Name of the person	CIN / DIN	Securities held prior to acquisition / disposal		Securities acquired / disposed			Securities held post acquisition / disposal		Date of allotment advice / acquisition of shares / sale of shares specify		Mode of acquisition / disposal	Date of intimation to company	Type of contract	Contract specification	Buy		Sell		Exchange on which the trade was executed	Notes
						No. of security	% of shareholding	No. of security	Value of security (in Rs.)	Transaction type	No. of security	% of shareholding	From date	To date					Notional value	No. of units (contracts × lot size)	Notional value	No. of units (contracts × lot size)
						No. of security	% of shareholding	No. of security	Value of security (in Rs.)	Transaction type	No. of security	% of shareholding	From date	To date					Notional value	No. of units (contracts × lot size)	Notional value	No. of units (contracts × lot size)
1	Equity		Designated Person	SALONI KHERA		14154	0.00%	1000	5,000.00	Buy	15154	0.00%	04-08-2026	04-08-2026	ESOP	05-08-2026							NA	Textual Information(1)
2	Equity		Designated Person	Pushkal Mishra		4000	0.00%	1500	487,515.00	Buy	5500	0.00%	04-08-2026	04-08-2026	ESOP	05-08-2026							NA	Textual Information(2)
3	Equity		Other	Dr. Lal PathLabs Employee Welfare Trust		606250	0.36%	11452	4,484,000.00	Sell	594798	0.35%	04-08-2026	04-08-2026	ESOP	05-08-2026							NA	Textual Information(3)
4	Equity		Designated Person	DEEPTI BHAYANA		2572	0.00%	780	3,900.00	Buy	3352	0.00%	04-08-2026	04-08-2026	ESOP	05-08-2026							NA	Textual Information(4)
5	Equity		Designated Person	Abhishek Maini		0	0.00%	1000	1,087,470.00	Buy	1000	0.00%	04-08-2026	04-08-2026	ESOP	05-08-2026							NA	Textual Information(5)
6	Equity		Designated Person	Punit Sharma		520	0.00%	1000	5,000.00	Buy	1520	0.00%	04-08-2026	04-08-2026	ESOP	05-08-2026							NA	Textual Information(6)
7	Equity		Designated Person	MRINAL KAPOOR		0	0.00%	2000	1,146,200.00	Buy	2000	0.00%	04-08-2026	04-08-2026	ESOP	05-08-2026							NA	Textual Information(7)
8	Equity		Designated Person	Abhishek Aggarwal		1250	0.00%	1250	2,385,174.00	Sell	0	0.00%	03-08-2026	04-08-2026	Market Sale	05-08-2026							NSE
9	Equity		Designated Person	Abhishek Aggarwal		0	0.00%	1250	726,273.00	Buy	1250	0.00%	04-08-2026	04-08-2026	ESOP	05-08-2026							NA	Textual Information(8)

Text Block

Textual Information(1)	It may be kindly noted that shares were acquired at an Exercise price of INR 5/- per share under Company’s ESOP Plan and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).
Textual Information(2)	It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 5/- & 965.025/- per share ( as the case maybe) under Company’s ESOP Plan(s) and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).
Textual Information(3)	It may be kindly noted that shares were transferred at Effective Exercise price (Post Bonus Issue- 2025) of INR 5/-, 1087.47/-,965.025/- & 1141.20/- per share (as the case may be) under Company’s ESOP plan(s).
Textual Information(4)	It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 5/- per sharE under Company’s ESOP Plan(s) and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).
Textual Information(5)	It may be kindly noted that shares were acquired at an Exercise price of INR 1087.47/- per share under Company’s ESOP plan.
Textual Information(6)	It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 5/- per share under Company’s ESOP Plan. and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).
Textual Information(7)	It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 5/- & 1141.20/- per share ( as the case maybe) under Company’s ESOP Plan(s).
Textual Information(8)	It may be kindly noted that shares were acquired at Effective Exercise price (Post Bonus Issue- 2025) of INR 5/-, 965.025/- per share (as the case maybe) under Company’s ESOP plan.